Detalhe da pesquisa
1.
The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
Proc Natl Acad Sci U S A
; 117(48): 30687-30698, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184176
2.
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
J Infect Dis
; 224(8): 1294-1304, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089610
3.
Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles.
J Infect Dis
; 218(suppl_5): S365-S387, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169850
4.
Anti-Nipah Virus Enzyme-Linked Immunosorbent Assays with Non-human Primate and Hamster Serum.
Methods Mol Biol
; 2682: 233-244, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610586
5.
Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters.
Antiviral Res
; 213: 105589, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003305
6.
Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models.
Antiviral Res
; 214: 105605, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068595
7.
Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties.
JCI Insight
; 7(1)2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807849
8.
Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses.
NPJ Vaccines
; 7(1): 166, 2022 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528644
9.
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients.
medRxiv
; 2022 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36415460
10.
Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors.
medRxiv
; 2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758897
11.
Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.
Viruses
; 13(5)2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34065987
12.
Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.
bioRxiv
; 2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688658
13.
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
J Clin Invest
; 131(3)2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320842
14.
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo.
Microorganisms
; 9(3)2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33801811
15.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants.
bioRxiv
; 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821267
16.
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
Sci Transl Med
; 13(616): eabj5413, 2021 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519517
17.
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
Antiviral Res
; 182: 104908, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798602
18.
A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.
Viruses
; 13(1)2020 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33396288
19.
A Model for the Production of Regulatory Grade Viral Hemorrhagic Fever Exposure Stocks: From Field Surveillance to Advanced Characterization of SFTSV.
Viruses
; 12(9)2020 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32872451
20.
Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19.
medRxiv
; 2020 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33052361